Gyre Therapeutics, Inc. (GYRE)
8.02
+0.20
(+2.56%)
USD |
NASDAQ |
Feb 13, 16:00
8.03
+0.01
(+0.12%)
After-Hours: 20:00
Gyre Therapeutics EPS Diluted (Quarterly) : 0.0349 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | -0.1193 |
| Savara, Inc. | -0.1366 |
| ADMA Biologics, Inc. | 0.1489 |
| Viridian Therapeutics, Inc. | -0.423 |
| Nutex Health, Inc. | 7.761 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.936M |
| Revenue (Quarterly) | 30.56M |
| Total Expenses (Quarterly) | 26.95M |
| Enterprise Value | 749.20M |
| Gross Profit Margin (Quarterly) | 94.67% |
| Profit Margin (Quarterly) | 19.42% |
| Earnings Yield | 0.47% |
| Operating Earnings Yield | 1.52% |
| Normalized Earnings Yield | 0.2469 |